Brian Case - 02 May 2022 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Source evidence 4 source fields
Form type
4
Accepted by SEC
28 Mar 2023, 17:21:37 UTC
Previous filing
22 Apr 2022
SEC filing
View on sec.gov
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Unger- Attorney-in-Fact

Key filing fact

Brian Case filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 28 Mar 2023.

Key facts

  • This page summarizes Brian Case's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 28 Mar 2023, 17:21.

Change

  • Previous filing in this sequence was filed on 22 Apr 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRMD transaction Derivative

Options to Purchase Common Stock

Award

Transaction value
$0
Shares
+475,000
Change %
Price
$0.000000
Shares after
475,000
Date
02 May 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
475,000
Exercise price
$2.67
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Non-Qualified options granted pursuant to the KORU Medical Systems, Inc. 2021 Stock Option Plan, as amended. Options vest in increments of 118,750 on the first anniversary of the date of grant and each anniversary thereafter until fully vested.

SEC remarks

Power of Attorney filed herewith as Exhibit 24.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .